Allspring Global Investments’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,296
Closed -$2.2M 1670
2025
Q2
$2.2M Sell
16,296
-43,197
-73% -$5.86M ﹤0.01% 1030
2025
Q1
$8.2M Sell
59,493
-50
-0.1% -$7.76K 0.01% 780
2024
Q4
$9.41M Sell
59,543
-72,498
-55% -$12.3M 0.02% 780
2024
Q3
$24.1M Sell
132,041
-802
-0.6% -$119K 0.04% 511
2024
Q2
$15.8M Buy
132,843
+41,935
+46% +$4.41M 0.03% 628
2024
Q1
$9.76M Sell
90,908
-13,345
-13% -$1.33M 0.02% 774
2023
Q4
$10.4M Buy
104,253
+25,626
+33% +$2.51M 0.02% 738
2023
Q3
$9.36M Sell
78,627
-244,427
-76% -$36.5M 0.02% 770
2023
Q2
$57.6M Sell
323,054
-19,393
-6% -$3.56M 0.09% 277
2023
Q1
$56.5M Buy
342,447
+45,242
+15% +$7.78M 0.09% 291
2022
Q4
$46.8M Buy
297,205
+41,090
+16% +$6.25M 0.08% 337
2022
Q3
$38.6M Sell
256,115
-7,809
-3% -$1.3M 0.07% 373
2022
Q2
$43.4M Sell
263,924
-14,191
-5% -$2.73M 0.07% 348
2022
Q1
$61.9M Buy
278,115
+207,003
+291% +$46.4M 0.08% 319
2021
Q4
$16.9M Buy
+71,112
New +$16.6M 0.02% 759

Other funds holding ICUI

Allspring Global Investments's ICUI Position: Q3 2025 in Review

Allspring Global Investments sold out of ICU Medical (ICUI) in Q3 2025, closing a stake of 16,296 shares — an estimated $2.2M sold.

Allspring Global Investments first reported a position in ICUI in Q4 2021 and held it in 15 quarters. The position peaked at $61.9M in Q1 2022. 270 funds tracked by Wall St. Rank hold ICUI as of Q3 2025.

  • Allspring Global Investments reported no remaining ICU Medical position as of Q3 2025 after selling out during the quarter.
  • Allspring Global Investments sold 16,296 ICU Medical shares in Q3 2025, an estimated $2.2M.
  • Allspring Global Investments first reported a position in ICU Medical in Q4 2021 and held it in 15 quarters.
  • Allspring Global Investments's ICU Medical position peaked at $61.9M in Q1 2022.
  • 270 funds tracked by Wall St. Rank held ICU Medical as of Q3 2025.

Based on Allspring Global Investments's 13F filing for Q3 2025, filed 20 Oct 2025.